ARCHIVE SEARCH
      -OR-  
 
  NEWS CHANNELS
Fitness News
Asthma Allergy News
Diabetes News
Women's Health News
 > Men's Health News

  MY NEWS
Personal Archive
My Account

  ABOUT THIS NEWSFEED
About Us
Advertise With Us
Feed Your Site
Contact Us


Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

 
Testosterone Therapy Doesn't Worsen Urinary Symptoms
About 30 percent of men experience an AUA symptoms index improvement of 3 or more points

MONDAY, Nov. 25, 2013 (HealthDay News) -- For hypogonadal men, testosterone replacement therapy is associated with a low risk of worsening lower urinary tract symptoms, according to a study published in the November issue of The Journal of Urology.

Jeffrey A. Pearl, from the Southern Illinois University School of Medicine in Springfield, and colleagues examined the effect of testosterone replacement therapy on lower urinary tract symptoms in a cohort of 120 hypogonadal men identified from an outpatient database. The American Urological Association symptom index (AUASI) was used to assess lower urinary tract symptoms before and after testosterone replacement therapy; patients were monitored for side effects of testosterone therapy.

The researchers found that the mean change in AUASI was −1.07 and mean change in prostate specific antigen was 0.44 ng/dL. Overall, 45.8, 31.7, and 22.5 percent of patients had less than a three-point AUASI change in either direction, an improvement of three or more points, and a worsening of three or more points, respectively. During the course of the study, 7.5 percent of men initiated new medications for lower urinary tract symptoms, with no significant change in AUASI for those with use of new medications or without use of lower urinary tract medications. Four patients (3.3 percent) had lower urinary tract symptom progression and needed transurethral resection of the prostate.

"Many men experience symptom improvement while changes in prostate specific antigen appear minor," the authors conclude.

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2013 HealthDay. All rights reserved.


Back to Top Stories
  GOOGLE ADS